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Abstract 
For several different proteins an apparent correlation has been observed between the 
propensity for dimerization by domain-swapping and the ability to aggregate into 
amyloid-like fibrils. Examples include the disease-related β2-microglobulin and 
transthyretin proteins. This has led to proposals that the amyloid-formation pathway may 
feature extensive domain swapping. One possible consequence of such an aggregation 
pathway is that the resulting fibrils would incorporate structural elements that resemble 
the domain-swapped forms of the protein, and thus reflect certain native-like structures 
or domain-interactions. In magic angle spinning solid-state NMR-based and other 
structural studies of such amyloid fibrils, it appears that multiple of these proteins form 
fibrils that are not native-like. Several fibrils instead have an in-register, parallel 
conformation, which is a common amyloid structural motif and is seen for instance in 
various prion fibrils. Such a lack of native structure in the fibrils suggests that the 
apparent connection between domain-swapping ability and amyloid-formation may be 
more subtle or complex than may be presumed at first glance.  
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We have recently reported1 on our magic-angle-spinning (MAS) solid-state NMR studies 
of the amyloid-like fibrils formed by a mutant form of the immunoglobulin binding domain 
B1 of streptococcal protein G (GB1). GB1 is a remarkably stable, small protein that has 
served as a model system for protein folding studies and has developed into a widely 
used test protein in both solution and solid-state NMR spectroscopy. One of its mutants 
has been found to form dimers in which a normally intra-molecular β-sheet, consisting of 
four β-strands β1-β4, becomes shared between the two proteins assembling into the 
dimer (see figure 1)2. This involves a domain-swapping event with the domains each 
consisting of a β-hairpin3. Interestingly, this same mutant was found to form amyloid-like 
fibrils, which the monomeric unmutated variant does not appear to do4. Based on 
evaluations of related mutants, including the examination of specific disulfide bond 
formation4, it appeared that there was a specific correlation between domain-swapping 
and amyloid-forming propensity. 
Domain-swapping and amyloid formation 
Such observations are of interest, as there have been indications that such a domain-
swapping mechanism may represent a more general aspect of amyloid formation5, 6. In 
particular, a domain-swapping based mechanism has been invoked for a number of 
amyloid-forming proteins - including some disease-related cases. The most prominent 
example has been the protein cystatin C, which causes cerebral amyloidosis7-11. Other 
cases where similar mechanisms are invoked are in the aggregation of transthyretin12 
and β2-microglobulin (β2m)13-15, as well as various other amyloid-forming proteins2, 4, 16-19.   
Characterization of the molecular pathway leading to amyloid formation, and thus the 
identification of a potentially shared mechanism based on domain-swapping, is of 
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interest for various reasons. Although there is some debate over the (most) toxic species 
in the various amyloid-related diseases, it is clear that protein aggregation (i.e., amyloid 
fibril formation) is by definition the most prominent shared feature of all of these 
disorders. There are strong indications that there is a correlation between disease 
(onset) and the aggregation of the proteins involved, even if the specific type of 
aggregate that matters most may an issue of debate. Thus, if we want to understand 
how these diseases are triggered, we need to probe not just the nature of the mature 
fibrils, but also the pathway leading to fibril formation and the various steps along the 
way.  
In various cases there are strong indications that the toxicity may be attributed to an 
oligomeric assembly of the protein involved, rather than the mature fibrils20. These toxic 
oligomers are transient intermediates, and can thus be difficult to study directly. 
Nonetheless, there is a need to understand their structure and formation. Identifying and 
understanding a domain-swapping based pathway of aggregation would provide 
important clues about the likely or potential structures of on-pathway early aggregates. 
Already, studies of domain-swapping amyloidogenic protein has suggested that the 
domain-swapped oligomeric species could be toxic19. In addition, a detailed structural 
analysis can yield a better appreciation of the role of native-like interactions or 
conformations, and how they may steer or initiate the aggregation process.  
Structural aspects  
It is by now well established that the central core of amyloid fibrils consists of long β-
sheets that involve β-strands from numerous protein monomers. These intermolecular β-
sheets can be arranged in different ways, but always feature extensive hydrogen 
bonding networks between the different peptide backbones. If we examine some of the 
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most commonly used case studies of domain-swapped dimers that are related to 
amyloid formation (e.g. Figure 2), then we see that in many of these dimers β-strands 
engage in antiparallel interactions with strands in other proteins, across the inter-domain 
(and inter-monomer) interface. Often these interactions in the domain-swapped dimer 
are intermolecular versions of normally intra-molecular β-sheets present in the 
monomeric native structure. This is for instance the case in the proposed structure for 
GB1 amyloid fibrils4, but also for many of the other proteins for which domain-swapping 
has been proposed to mediate their amyloid formation. Figure 2 shows a number of 
different dimeric structures for such proteins, based on solution NMR or X-ray 
crystallographic studies8, 13, 14, 21, 22. 
Structurally it would seem reasonable to extrapolate the domain swapping beyond a 
dimeric assembly, as the observed β-sheet-based interactions could be accommodated 
in even longer β-sheets involving more proteins. This is shown schematically in Figure 
1c. Such a model would predict that the amyloid core is formed from extensively inter-
molecular β-sheets that contain the same native-like β-strands that are observed in the 
domain-swapped dimers, and would likely incorporate antiparallel β-strand interactions 
and β-hairpins (in analogy to the dimeric structures in Figure 2).  
Clearly, this would present a seemingly elegant model for the formation of amyloid β-
sheet structures, and explain the apparent correlations between domain swapping 
propensity and amyloid formation. Indeed, studies have reported various biochemical 
data that appear to be consistent with this general concept. In a number of different 
studies, selectively introduced disulfide bonds have been used to probe and control the 
interactions between domains and to observe the effect on amyloid formation as well as 
domain-swapping. Along with data suggesting the presence of native-like structures in 
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the fibrils or at least the early aggregates, these experiments appeared to support the 
formation of ‘domain-swapped fibrils’ that preserve the structural features typical of the 
dimeric forms and the native protein. Evidence of native-like structure has taken a 
variety of forms. Non-fibrillar toxic aggregates of p13suc1 were found to resemble the 
native form of the protein in terms of similar fluorescence and CD spectra, 
hydrogen/deuterium exchange characteristics, and protease sensitivity (monitored by 
SDS PAGE and mass spectrometry)19. In addition, there was a correlation between the 
amount of aggregation and the domain-swapping propensity of different mutants19. 
Activity-based evidence for domain-swapped mature fibrils was obtained in the elegant 
work by Sambashivan et al17, where fibrils were prepared from mixtures of individually 
inactive RNase A variants featuring inserts based on amyloidogenic polyQ or 
GNNQQNY elements. The resulting fibrils showed enzymatic activity that required the 
swapping of domains from different mutants, thus revealing a native-like, but domain-
swapped structure of functional domains, presumably with a ‘fibril backbone’ of β-sheets 
formed by the above-mentioned ‘inserts’ 17. Another approach for probing domain-
swapped fibrils is through the incorporation of disulfide bonds within or between 
domains4, 10, 18, 23. 
Evidence for non-native mature fibrils 
One crucial question in an aim to further validate this elegant and tempting mechanism 
is the structural characterization of the resulting fibrils on an atomic or molecular level. 
Two spectroscopic techniques that can provide such information are electron 
paramagnetic resonance (EPR) and solid-state NMR spectroscopy. Employing spin-
labeled proteins or peptides, EPR can provide constraints on the fibril structure, 
indicating intra- but also (and importantly) inter-molecular proximities of specific residues 
24.  Similarly, magic-angle-spinning solid state NMR provides structural data reflecting 
 8
the intramolecular and supramolecular assembly of amyloid fibrils 25, 26. Gradually such 
studies are expanding our knowledge of common structural motifs in the fibrils. In 
addition, such methods have allowed the direct examination the structural similarities 
between fibrillar and crystalline aggregates of amyloid-forming peptide fragments 27, 28. 
Analogously, these methods can provide the necessary data to detect the presence or 
absence of native-like structure in the mature fibrils formed by domain-swapping 
amyloidogenic proteins, in order to test the type of structural model as illustrated in 
Figure 1c. 
However, our MAS NMR studies of the mature fibrils of the GB1 model protein failed to 
reveal the anticipated native-like conformations 1. No evidence was found for the native 
α-helix, nor for the intramolecular β-hairpins that are present in both the native 
monomeric conformation and in the domain-swapped dimers. Instead, the amyloid fibrils 
are highly rigid, predominantly β-sheet in structure, and adopt an in-register parallel (IP) 
conformation. An examination of the literature also revealed evidence for such IP 
assemblies for various of the proteins proposed to undergo domain-swapping as part of 
the amyloid-formation process, based on MAS NMR and EPR. For example, studies of 
fibrils of β2m by both EPR and MAS NMR indicated a non-native IP structure 29-31. 
Similar studies of the human prion protein, which has also been implicated in a domain-
swapping associated aggregation pathway, have come to similar conclusions 32, 33. 
Some experimental studies of transthyretin fibrils have supported a non-native, possibly 
IP β-sheet assembly 23, 34. On the other hand, a recent NMR study yields structural 
constraints for transthyretin fibrils that indicate a fibril core structure that is neither native-
like nor parallel in-register, and suggests that this may reflect a polymorphic form occurs 
alongside a more native-like fibril conformation35, 36. 
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It is perhaps worth pointing out here that this parallel in-register conformation reflects a 
commonly recurring motif in amyloid fibril structure 24, 37. This structural motif has 
recently been referred to as a β-arcade 37, and is illustrated in Figure 3. This type of 
assembly has been found in many different amyloid fibrils, including for instance 
amyloid-β and various yeast prion proteins. It aligns the peptide backbones such that 
they can participate in the hydrogen bonding networks that are thought to provide much 
of the stability typical of most amyloid fibrils38. It also results in a natural alignment of the 
same residue position in different monomers, within the fibrils, thus permitting stabilizing 
interactions via side chains of many residues: e.g. by clustering hydrophobic residues, 
the generation of hydrogen-bonded Gln/Asn ladders and through favorable interactions 
among aromatic residues. Charged residues may necessitate compensating counter-
charges nearby or may be predominantly present in loop regions that intersperse the β-
strands that assemble the amyloid core.  
One consequence of the characteristic same-same interactions in these IP assemblies is 
that there is a class of experiments that can specifically probe such interactions, as 
illustrated in Figure 3. For MAS NMR this includes a variety of methods, typically relying 
on the specific isotopic (13C) labeling of individual residues or even atoms, and detecting 
the proximity (or lack thereof35) of the same labels in the corresponding residues in 
neighboring monomers26. There are similar approaches using site-specific spin labels in 
EPR24. These types of interactions are much less likely to be seen in structures where β-
strands are not ‘stacked’ in a parallel in-register manner (see Figure 3). Note that all the 
domain-swapped dimers shown in Figure 2 feature an antiparallel alignment of the β-
strands that form the dimer-interface. Furthermore, based on some of the observed 
domain-swapping, one may expect the inclusion of intramolecular β-hairpins within the 
fibrillar β-sheets, which would also prevent the same close proximity of same-to-same 
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residues in different monomers (Fig. 3a). Aside from these spectroscopic approaches, 
similar conclusions may be drawn on the basis of e.g. intermolecular disulfide bond 
formation23.  
Role for domain-swapping? 
Based on such studies of the associated fibrils, it appears that at the least for a number 
of domain-swapping proteins the mature fibrils do not feature the predicted (e.g. Figure 
1) native-like structural elements, but rather adopt the seemingly common β-arcade 
amyloid motif with IP β-sheets37 (or other non-native structure35. What then could be the 
role of domain-swapping in amyloid formation of these various proteins?  
One intriguing possibility is that the domain-swapping-related structural rearrangements 
play critical roles in the early stages of the aggregation process. It has been noted that 
the early aggregation states do feature native-like structures for e.g. β2m and the GB1 
amyloids 4, 39. It is quite possible for the initial aggregates and the mature fibrils to feature 
different conformations, as these reflect kinetically as well as structurally distinct events 
along the aggregation pathway. Structural studies of the different intermediate states 
along the pathway are challenging due to their transient nature. There are studies that 
suggest a role for transient α-helical structure in early oligomeric aggregates, which is 
lost upon formation of fibrils, in particular for inherently disordered proteins or peptides 
40-42. In contrast, MAS NMR studies of Aβ oligomers seems to show a highly β-sheet rich 
assembly that is relatively similar to the secondary sheet elements in the mature fibrils43.   
One thing that differs for the domain-swapping proteins compared to these examples is 
that they do have an ordered native conformation. This implies that a partial 
destabilization of the ordered native conformation has to be achieved in order for 
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amyloid formation to take place. Similarly, a partial unfolding must accompany the 
domain-swapping into the dimeric assemblies (Figure 4b). Thus, the domain-swapping 
propensity may play a role at the step of destabilizing the native state, and possibly in 
the subsequent first steps of the aggregation process.  
If these initial steps result in a somewhat native-like oligomeric species that indeed 
shares structural features with the domain-swapped dimers (ref. figure 4), this could 
account for the experimental data indicating native structure at this stage of aggregation. 
Note that the toxic, non-fibrillar aggregates of p13suc1 (see above) seem to match such 
a description19. Native-like early aggregates may well lead to ‘domain-swapped’ fibrils16, 
in a way that is consistent with a templated elongation process (Figure 4c)44. However, 
as delineated above, much of the structural fibril data appear thus consistent with the 
generation of structurally different amyloid fibrils (Figure 4d) that are parallel, in-register 
and thus reflect a loss of native structure – as we reported for the GB1 amyloid fibrils1. A 
significant structural rearrangement between the oligomeric and fibrillar states is not 
necessarily unexpected 37, 41, although unambiguous evidence for this is still lacking. 
Given the potential involvement of this mechanism in a number of different amyloid-
related disorders and the interest in the oligomer structure due to the potential toxic role 
of these species, further studies to examine this issue are clearly warranted. As with the 
characterization of transient oligomeric species in other amyloid diseases, such studies 
will pose some practical challenges but should be of great value to elucidate the 
aggregation process and possibly the nature of the toxic species. 
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Figure Legends 
Figure 1 – (a) Structure of monomeric GB1 (PDB ID 2JSV) 45, along with schematic 
cartoon showing the β-hairpin ‘domains’. (b) domain-swapped dimer of mutant GB1 
(PDB 1Q10) 2, with a color-coded cartoon illustrating the domain swapped β-hairpin 
‘domains’ (c) Highly schematic representation of a hypothetical assembly pattern for 
amyloid fibrils, based on extensive, intermolecular domain swapping 4. 
 
Figure 2 – Structures of domain-swapped dimers associated with amyloid formation. (a) 
bovine pancreatic RNase A (PDB 1A2W) 21, (b) p13suc1 tetramer (1SCE) 22, (c) human 
cystatin C (1TIJ)8, (d) antibody bound tetramer of β2m (2X89) 13, and (e) β2m dimer 
(3LOW) 14. Individual monomers are color-coded. In each of these assemblies the 
interface is largely mediated by hydrogen bonding of antiparallel β-strands from two 
different monomers. 
 
Figure 3 – Domain-swapped interfaces are commonly anti-parallel (a) and sometimes 
involved intra-sheet β-hairpins (b). This contrasts to the in-register parallel conformation 
(c), as experimentally observed for several of the actual fibrils. These measurements 
often include the detected of the same-to-same contacts that characterize the IP 
structure, as illustrated in (d) based on an IP peptide amyloid conformation 28, 46. Black 
spheres illustrate the varying positioning and proximity of identical labeled sites in 
different monomers. 
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Figure 4 – Schematic illustration of domain-swapping mechanisms in amyloid formation. 
(a) The formation of domain-swapped dimers follows the flexing and partial unfolding of 
different domains relative to each other. Partial unfolding is also a pre-requisite for 
amyloid formation and may yield native-like oligomers with structural features that relate 
to ‘run-away domain-swapping’ 5, 18. (b) This may lead to the formation of amyloid fibrils 
that have native-like structure. However, various experimentally characterized amyloid 
fibrils do not show native-like structure (see text). (c) In those cases, a somewhat native-
like oligomeric species may have undergone significant structural rearrangements, to 
yield a more canonical amyloid fibril lacking native structure, featuring for instance in-
register parallel β-sheets,.   
 
 




